Filling the Trevi fountain with my 2 centsOctober around the corner
Like most of us, I am still unaware of how much Ceapro has in the works and in the pipeline.
All I can hope is that there is lots in the pipeline and hopefully much that can not be disclosed.
Optomistically, the reason the stock price is not moving is due to 1) the insiders not buying because they are satisified with their stock options, current positions and putting their money in their family houses in Canada. 2) The market is still dubious about the company and hopefully when the uplisting takes place, or some deal announcement the stock price will correct.
If all the above is not correct or things turnout much worse, I doubt the valuation can drop much until the end of 2019.
That said, there is 3 months left for Gagnon to deliver before end of year.
Best of luck mostly to the ones who have averaged down and who are working on their patience skills.